IMF Virtual Regional Community Workshop (RCW) - Southwest 2021
June 26, 2021
10:00 AM PT/12:30 PM PT
This International Myeloma Foundation Regional Community Workshop offers myeloma patients and caregivers up-to-the-minute information about multiple myeloma. Topics include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. Also, a member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and treatments. Question and answer segments will follow each presentation with the experts allowing ample time for the audience to ask questions.
We hope you will join us!
Welcome and Announcements
Kelly Cox, Senior Director IMF Regional Community Workshops
Myeloma 101 and Frontline Therapy
Joseph Mikhael, MD, MEd (IMF Chief Medical Officer, TGen, Phoenix, AZ) reviews multiple myeloma basics including what myeloma is, common symptoms and side effects, advances in how myeloma is initially diagnosed, the stages of myeloma treatment, induction therapy, transplant, and more.
Relapsed Therapy and Clinical Trials
Amrita Krishnan, MD FACP (City of Hope Medical Center, Duarte, CA) discusses the types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, updates on clinical trials, and more.
How to Manage Symptoms and Side Effects
Deborah Doss, RN, OCN (IMF Nurse Leadership Board) discusses how patients can manage myeloma-related symptoms and side effects along with side effects brought on by treatment. He outlines the most common side effects for each myeloma drug category, how to prevent infection, and more.
Download the IMF's Multiple Myeloma Informational Booklets:
With Support From: Amgen, Bristol Myers Squibb, GSK, Janssen, Karyopharm Therapeutics, Oncopeptides, and Takeda Oncology